Table. 1.

General characteristics of study population with and without diabetic retinopathy (DMR)

Variables Total Without DMR With DMR P-value
Number Weighted % (SE) Number Weighted % (SE) Number Weighted % (SE)
Age, y 434 61.5 (0.56) 351 61.7 (0.60) 83 60.7 (1.32) 0.484
Age group, y 0.440
40–49 52 15.7 (2.24) 42 16.1 (2.61) 10 14.2 (4.51)
50–59 108 32.1 (2.89) 84 30.4 (2.93) 24 38.9 (6.42)
60–69 124 22.6 (2.01) 99 22.4 (2.26) 25 23.5 (4.45)
>70 150 29.6 (2.14) 126 22.4 (2.26) 24 23.4 (4.79)
Sex, female 203 42.5 (2.80) 169 43.4 (3.34) 34 38.5 (6.26) 0.522
DM diagnosed y 322 53.8 (0.79) 250 54.9 (0.86) 72 50.2 (1.40) 0.003
Employed 217 55.7 (2.93) 170 53.4 (3.30) 47 64.4 (5.73) 0.102
Smoking 83 20.6 (2.31) 60 17.5 (2.37) 23 33.3 (5.95) 0.006
Alcohol 195 47.2 (2.44) 160 48.5 (2.93) 35 42.1 (5.34) 0.329
Exercise
Aerobic 79 22.2 (2.63) 68 23.4 (2.63) 11 17.2 (6.66) 0.410
Muscle strength 76 20.4 (2.55) 61 20.5 (2.87) 15 20.1 (4.72) 0.931
Walking 308 79.3 (2.32) 250 80.2 (2.60) 58 75.8 (5.58) 0.464
Health screening 299 73.1 (2.38) 234 70.3 (2.61) 65 84.1 (4.24) 0.013
Fundus exam, yes 111 25.6 (2.50) 81 23.2 (2.49) 30 35.6 (6.44) 0.044
HbA1C, % 434 7.1 (0.09) 351 7.0 (0.08) 83 7.7 (0.26) 0.005
FBS, g/dL 434 141.4 (2.39) 351 136.5 (1.99) 83 161.7 (8.38) 0.004
Co-morbidity
Hypertension 240 51.6 (2.87) 197 53.5 (3.00) 43 43.7 (6.11) 0.139
Hyperlipidemia 173 41.3 (3.20) 139 41.6 (3.73) 34 40.2 (6.18) 0.849
Cerebral Inf. 20 4.5 (1.10) 13 3.8 (1.11) 7 7.3 (2.74) 0.150
DM treatment, yes 303 68.6 (2.57) 234 65.6 (2.90) 69 80.8 (4.60) 0.012
Insulin 25 5.2 (1.19) 15 4.3 (1.17) 10 9.1 (2.79) 0.041
OHA 298 67.7 (2.57) 230 64.5 (2.86) 68 80.6 (4.60) 0.007
Non-drug 30 7.2 (1.30) 24 6.3 (1.21) 6 10.7 (4.71) 0.295

DM, diabetes mellitus; HbA1C, glycated hemoglobin; FBS, fasting blood sugar; Cerebral Inf., cerebral infarction; OHA, oral hypoglycemic agents; SE, standard error.

P-values were determined using the Rao-Scott chi-square test.

Korean J Fam Pract 2021;11:177~183 https://doi.org/10.21215/kjfp.2021.11.3.177
© KJFP